Bayerische Patentallianz, the tech transfer organisation for institutions in Bavaria, has welcomed Robert Phelps as its managing director.
Robert Phelps (pictured) was appointed managing director of Bayerische Patentallianz (BayPat) on Sunday.
BayPat is the tech transfer organisation for 33 Bavarian universities, university hospitals and universities of applied sciences and research institutes.
Phelps replaces Peer Biskup, who held the position for approximately 10 years. Phelps joined from clinical-stage biotechnology developer Lophius Biosciences, where he acted as chief executive.
He was previously head of business development and licensing at autoimmune disease treatment developer Suppremol, leading the way on its €200m acquisition by pharmaceutical firm Baxalta.
He holds a PhD in biochemistry from University of Frankfurt and Paul-Ehrlich-Institut, and has a Certified Licensing Professional accreditation.
– Image courtesy of Bayerische Patentallianz
